We are more than a just standards development organization – we are a problem-solving forum for the healthcare industry. Over the years, we have made numerous contributions to improving efficiencies and patient safety not only through our standards but also through industry guidance. Our industry guidance is traditionally published in the form of a white paper.
Industry guidance spans a variety of topics including: the use of the Quantity Prescribed to address Schedule II controlled substances; Medicaid Drug Rebate Program; Billing Guidance for Pharmacists' Professional and Patient Care Services; and Dates Associated with Pharmaceutical Products.
Some examples of our industry guidance include the following: